The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Beckman Daniella since 2024.
This trader's CIK number is 1513422.
At the time of last reporting, Beckman Daniella was the Chief Financial Officer of Tango Therapeutics, Inc.. (stock ticker symbol TNGX).
Also see all insider trading activities at Tango Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | TNGX | 0 | $0 | 8,232 | $25,279 | 0 | $0 |
| 2024 | TNGX | 0 | $0 | 3,725 | $46,900 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-02-05 | TNGX | Sale | 3,948 | 3.16 | 12,479 |
| 2025-02-04 | TNGX | Sale | 4,284 | 2.99 | 12,800 |
| 2024-02-07 | TNGX | Sale | 1,817 | 12.62 | 22,930 |
| 2024-02-06 | TNGX | Sale | 1,908 | 12.56 | 23,970 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Beckman Daniella (Chief Financial Officer of Tango Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.